Product/Composition:- | Atenolol tablets |
---|---|
Strength:- | 25 mg, 50 mg, 100 mg |
Form:- | Tablets |
Reference Brands:- | Tenormin(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Atenolol is a selective beta-1 blocker that reduces heart rate, blood pressure, and cardiac workload by inhibiting adrenaline's effects on the heart. It effectively treats hypertension, angina, and arrhythmias, decreasing the risk of heart attacks, improving heart function, and supporting cardiovascular health and long-term disease management.
Atenolol tablets, marketed as Tenormin, are approved in the US by the FDA and in the EU via EMA for hypertension, angina, and arrhythmias. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews clinical trial and manufacturing data, while the EMA guarantees compliance with regional safety and quality standards. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence ensures timely approval, safe use, and worldwide availability, helping improve cardiovascular health outcomes across global markets.